INTERVIEW: Carmat stays on the beat with potential 2016 artificial heart CE mark
This article was originally published in Clinica
Executive Summary
Carmat has taken another step towards approval of its biocompatible artificial heart after developing a portable console that has allowed one patient implanted with the system to return home.
You may also be interested in...
News We’re Watching: Abbott FreeStyle Libre Recall, Medtronic Partners With DaVita, Free SBOM Software
This week, Abbott announced a class I recall of several glucose management systems. Additionally, Medtronic announced partnerships with DaVita and Qure.Ai; Heartflow closed a funding round; and BiVacor readies for artificial heart trials.
Carmat To Launch Total Artificial Heart In Early 2021
After years of setbacks, the company will launch its device in Europe as a bridge to transplant in heart failure patents.
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.